tirzepatide for mash Newly released phase IIb 48-week liver biopsy data on #tirzepatide in #MASH. 73.9% resolution of with no worsening of fibrosis on 15 mg. Secondary endpoint ⬇️ fibrosis by >1 stage Tirzepatide for MASH :- Medznat

Frequently Asked Questions Both medications contain semaglutide and belong to the same class of drugs

George JS, Srouji SS, Little SE, Ginsburg ES, Lanes A

Four of the GLP-1RAsalbiglutide, dulaglutide, semaglutide, and liraglutideare GLP-1 analogs, modified from the native structure of GLP-1, while exenatide and lixisenatide are based on the peptide exendin (a hormone derived from the saliva of the Gila monster), which has a similar structure to that of GLP-1 and retains GLP-1 activity [4]

Abbott Diabetes Care, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Menarini Pharmaceuticals, Merck Sharp & Dohme and NovoNordisk

Providers should approach compounding partnerships with thorough due diligence, transparent patient communication about the non-FDA-approved status of compounded products, and current legal guidance on the regulatory environment

Rapid weight loss in the first weeks of treatment involves significant loss of glycogen stores, and glycogen holds water roughly 3 to 4 grams of water per gram of glycogen